These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 1347240)

  • 21. Negative symptoms as a risk factor for tardive dyskinesia in schizophrenia.
    Liddle PF; Barnes TR; Speller J; Kibel D
    Br J Psychiatry; 1993 Dec; 163():776-80. PubMed ID: 7905774
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predictors of improvement in tardive dyskinesia following discontinuation of neuroleptic medication.
    Glazer WM; Morgenstern H; Schooler N; Berkman CS; Moore DC
    Br J Psychiatry; 1990 Oct; 157():585-92. PubMed ID: 1983390
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Late onset involuntary movements in chronic schizophrenia: relationship of 'tardive' dyskinesia to intellectual impairment and negative symptoms.
    Waddington JL; Youssef HA
    Br J Psychiatry; 1986 Nov; 149():616-20. PubMed ID: 2880630
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cognitive functions in tardive dyskinesia.
    Wolf ME; Ryan JJ; Mosnaim AD
    Psychol Med; 1983 Aug; 13(3):671-4. PubMed ID: 6137851
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The prediction of chronic persistent versus intermittent tardive dyskinesia. A retrospective follow-up study.
    Glazer WM; Morgenstern H; Doucette JT
    Br J Psychiatry; 1991 Jun; 158():822-8. PubMed ID: 1678663
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dyskinetic movements, cognitive impairment, and negative symptoms in elderly neuropsychiatric patients.
    Karson CN; Bracha HS; Powell A; Adams L
    Am J Psychiatry; 1990 Dec; 147(12):1646-9. PubMed ID: 2244644
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gender differences in tardive dyskinesia: a critical review of the literature.
    Yassa R; Jeste DV
    Schizophr Bull; 1992; 18(4):701-15. PubMed ID: 1359633
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The association among negative symptoms, movement disorders, and frontal lobe psychological deficits in schizophrenic patients.
    Brown KW; White T
    Biol Psychiatry; 1991 Dec; 30(12):1182-90. PubMed ID: 1686411
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tardive dyskinesia and dementia.
    Famuyiwa OO; Eccleston D; Donaldson AA; Garside RF
    Br J Psychiatry; 1979 Dec; 135():500-4. PubMed ID: 43754
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nifedipine in the treatment of tardive dyskinesia.
    Duncan E; Adler L; Angrist B; Rotrosen J
    J Clin Psychopharmacol; 1990 Dec; 10(6):414-6. PubMed ID: 1981070
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The prevalence of tardive dystonia in patients with chronic schizophrenia.
    Sachdev P
    Aust N Z J Psychiatry; 1991 Dec; 25(4):446, 448. PubMed ID: 1686546
    [No Abstract]   [Full Text] [Related]  

  • 32. Vulnerability to tardive dyskinesia.
    Wolf ME; DeWolfe AS; Ryan JJ; Lips O; Mosnaim AD
    J Clin Psychiatry; 1985 Sep; 46(9):367-8. PubMed ID: 2863257
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Schizophrenia and severe tardive dyskinesia responsive to risperidone.
    Kopala LC; Honer WG
    J Clin Psychopharmacol; 1994 Dec; 14(6):430-1. PubMed ID: 7533794
    [No Abstract]   [Full Text] [Related]  

  • 34. Tardive dyskinesia. A discontinuation study.
    Glazer WM; Moore DC; Schooler NR; Brenner LM; Morgenstern H
    Arch Gen Psychiatry; 1984 Jun; 41(6):623-7. PubMed ID: 6145399
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tardive dyskinesia in bipolar affective disorder: aging, cognitive dysfunction, course of illness, and exposure to neuroleptics and lithium.
    Waddington JL; Youssef HA
    Am J Psychiatry; 1988 May; 145(5):613-6. PubMed ID: 2895985
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Never treated schizophrenic patients have no abnormal movements such as tardive dyskinesia].
    Chorfi M; Moussaoui D
    Encephale; 1985; 11(6):263-5. PubMed ID: 2869939
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relation of neuroleptic dose and tardive dyskinesia to attention, information-processing, and psychophysiology in medicated schizophrenics.
    Spohn HE; Coyne L; Lacoursiere R; Mazur D; Hayes K
    Arch Gen Psychiatry; 1985 Sep; 42(9):849-59. PubMed ID: 2864028
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment programme and long-term outcome in chronic schizophrenia.
    Kane JM
    Acta Psychiatr Scand Suppl; 1990; 358():151-7. PubMed ID: 1978476
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Movement disorders and psychological tests of frontal lobe function in schizophrenic patients.
    Brown KW; White T; Palmer D
    Psychol Med; 1992 Feb; 22(1):69-77. PubMed ID: 1349440
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tardive dyskinesia: relation to computer-tomographic, endocrine, and psychopathological variables.
    Albus M; Naber D; Müller-Spahn F; Douillet P; Reinertshofer T; Ackenheil M
    Biol Psychiatry; 1985 Oct; 20(10):1082-9. PubMed ID: 2864087
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.